Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.00 | 3.00 | 0.00 |
Stocks | 97.00 | 97.00 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.27 | 11.46 |
Price to Book | 1.52 | 1.38 |
Price to Sales | 0.80 | 0.95 |
Price to Cash Flow | 7.52 | 6.09 |
Dividend Yield | 3.07 | 3.96 |
5 Years Earnings Growth | 8.86 | 9.56 |
Name | Net % | Category Average |
---|---|---|
Industrials | 25.86 | 14.37 |
Healthcare | 14.81 | 10.78 |
Consumer Cyclical | 13.46 | 11.44 |
Basic Materials | 11.80 | 7.59 |
Financial Services | 10.17 | 20.57 |
Consumer Defensive | 10.10 | 9.63 |
Technology | 6.48 | 8.64 |
Communication Services | 4.13 | 6.14 |
Energy | 2.97 | 7.04 |
Real Estate | 0.21 | 1.91 |
Number of long holdings: 86
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Berkshire Hathaway B | US0846707026 | 3.82 | 467.70 | -0.09% | |
Roche Holding Participation | CH0012032048 | 3.29 | 256.20 | -2.06% | |
J&J | US4781601046 | 3.12 | 151.87 | -0.89% | |
Alphabet A | US02079K3059 | 3.05 | 175.58 | -1.84% | |
Safran | FR0000073272 | 3.02 | 218.60 | +0.05% | |
FMC | US3024913036 | 2.82 | 55.48 | -0.45% | |
Deutsche Post | DE0005552004 | 2.78 | 35.310 | +0.57% | |
Kemira Oyj | FI0009004824 | 2.65 | 19.36 | -0.21% | |
Ionis Pharma | US4622221004 | 2.58 | 37.23 | -1.46% | |
Novartis | CH0012005267 | 2.46 | 91.93 | -0.86% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tweedy, Browne Global Value | 5.22B | 4.53 | 3.07 | 4.85 | ||
Tweedy, Browne Value | 415.22M | 4.27 | 4.56 | 5.37 | ||
Tweedy, Browne Worldwide Hi Div Yld | 63.79M | 9.79 | 5.39 | 4.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review